<DOC>
	<DOCNO>NCT01092143</DOCNO>
	<brief_summary>This 6 week study investigate effectiveness safety BI 671800 ED patient asthma take inhaled corticosteroid .</brief_summary>
	<brief_title>BI 671800 ED Steroid-naive Asthmatic Patients</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Inclusion criterion : 1 . Signed informed consent consistent ICHGCP 2 . Three month history reversible ( 12 % 200 mL ) asthma ( accord GINA ) follow spirometry randomization : FEV1 60 % 85 % . 3 . No ICS previous 3 month prior screen . 4 . Diagnosis asthma prior 40 year . 5 . ACQ least 1.5 randomization . 6 . Male female , 18 65 year . 7 . Nonsmokers exsmokers ( less 10 pack year history ) negative cotinine screen . 8 . Able perform PFT Exclusion criterion : 1 . Significant disease asthma allergic rhinitis . 2 . Hepatic transaminase total bilirubin great 1.5 ULN . 3 . Hospitalizations asthma asthma relate intubation within 3 month . 4 . Uncontrolled asthma . 5 . Respiratory tract infection exacerbation within 4 week . 6 . FEV1 le 40 % , 12 puff SABA two consecutive day asthma exacerbation runin period . 7 . Participation another interventional study . 8 . Pregnant nursing woman . 9 . Women child bear potential use appropriate method birth control define protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>